Q&A: UNC's McCleod Discusses 'Practical' Approach to Bringing Pharmacogenetics to All Countries

"We often try to have these heroic 50,000-patient studies out there. Really, a little bit of biological plausibility is all that is needed," said Howard McLeod, head of the Pharmacogenetics in Every Nation Initiative.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.